SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cadila Healthcare
Cadila Healthcare
BSE: 532321|NSE: CADILAHC|ISIN: INE010B01019|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 23, 17:00
1377.50
10.3 (0.75%)
VOLUME 1,637
LIVE
NSE
Oct 23, 17:00
1376.85
7.2 (0.53%)
VOLUME 9,934
News on Cadila Healthcare
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Cadila Healthcare' Q2 results on Nov 06, 2014

9.10 pm | 13 Oct 2014 |  Source: Moneycontrol.com

Cadila Healthcare's board meeting will be held on November 06, 2014, inter alia, to consider and approve the unaudited financial results for the quart...

Here's why pharma sector will continue outperforming

2.53 pm | 11 Oct 2014 |  Source: Moneycontrol.com

Analysts at Motilal Oswal believe that Lupin, Ranbaxy, Cadila Healthcare, GSK Pharma, Torrent Pharma and Alembic Pharma will report stronger overall o...

Buy Cadila Health, Canara Bk, Capital First: Dharmesh Kant 

1.58 pm | 09 Oct 2014 |  Source: CNBC-TV18

Dharmesh Kant of India Nivesh Securities is of the view that one can buy Capital First for a target price of Rs 330 and Canara Bank for a target price...

Why action is unlikely in US generics pricing probe

1.12 pm | 09 Oct 2014 |  Source: Moneycontrol.com

A JM financial probe said that the probability of any major action against generic pharma companies accused of inflating generic drug prices is low be...

Bull's Eye: Buy BHEL, NTPC, REC, Ahmednagar Forgings 

8.43 am | 09 Oct 2014 |  Source: CNBC-TV18

Dharmesh Kant, India Nivesh Securities advises buying Ahmednagar Forgings for a target price of Rs 430 and Cadila Healthcare for a target price of Rs ...

Super Six intraday picks for the day 

8.16 am | 09 Oct 2014 |  Source: CNBC-TV18

Vishal Kshatriya of Edelweiss advises buying Bharat Heavy Electricals with a target of Rs 220 and Cadila Healthcare with a target of Rs 1450....

US Cong probe unusual, may add more drug players: PharmAsia 

4.17 pm | 08 Oct 2014 |  Source: CNBC-TV18

According to Vikas Dandekar, the scale of investigation by the US Congress is unprecedented and so 10 drugs and 14 generic companies as of now looks l...

US price hike probe: Sun Pharma, DRL, Cadila tank 2-5%

11.46 am | 08 Oct 2014 |  Source: CNBC-TV18

This probed seems to be triggered by National Community Pharmacists Association (NCPA) 2013 survey of drug prices. In 2014, the NCPA had written to th...

Bull's Eye: Buy Arvind, Cadila Health; short Sesa Sterlite 

8.50 am | 08 Oct 2014 |  Source: CNBC-TV18

AK Prabhakar, Independent Advisor advises buying Arvind for a target price of Rs 340 and Sobha Developer for a target price of Rs 488....

Buy Cadila Healthcare; tgt of Rs 1410: Firstcall Research

1.14 pm | 01 Oct 2014 |  Source: Moneycontrol.com

Firstcall Research is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target of Rs 1410 in its September 26, 2014 rese...

Buy Cadila Healthcare: Manas Jaiswal 

3.21 pm | 26 Sep 2014 |  Source: CNBC-TV18

Manas Jaiswal, Technical Analyst at manasjaiswal.com recommends buying Cadila Healthcare as the stock may head above Rs 1300....

Short Nifty with stop loss of 7925, says Manas Jaiswal 

1.24 pm | 26 Sep 2014 |  Source: CNBC-TV18

In an interview with CNBC-TV18’s Reema Tendulkar and Sumaira Abidi, Manas Jaiswal, Technical Analyst at manasjaiswal.com shares his views on various...

Prefer Cipla, Cadilla Healthcare: Sandeep Bhatia 

12.32 pm | 22 Sep 2014 |  Source: CNBC-TV18

According to Sandeep Bhatia, Executive Director & Head of Sales at Kotak Institutional Equities, one may prefer Cadilla Healthcare and Cipla from the ...

Stocks in news: Tata Motors, GTL Infra, ICICI, Cipla, SPML

8.22 am | 19 Sep 2014 |  Source: CNBC-TV18

Tata Motors | Tata Chemicals | Tata Steel | Tata Power | Tech Mahindra | Bosch | GTL Infrastructure | SBI | Axis Bank | ICICI Bank | Manappuram Financ...

Cadila Health up 3%, diabetic drug gets tentative USFDA nod

2.23 pm | 16 Sep 2014 |  Source: Moneycontrol.com

"Zydus Cadila has received tentative approval from the US Food and Drug Administration (US FDA) to market (anti-diabetic drug) Glipizide extended rele...

Zydus receives tentative approval for Glipizide ER tablets

12.13 pm | 16 Sep 2014 |  Source: Moneycontrol.com

Zydus Cadila has received tentative approval from USFDA to market Glipizide extended-release tablets in the strength of 2.5 mg, 5 mg and 10 mg. The dr...

Hope rally over: Why you should go back to 'boring sectors'

12.36 pm | 15 Sep 2014 |  Source: Moneycontrol.com

“The Street is building in a capex cycle of the likes in 2004 and 2008,” Elara says, adding, “while we do not dispute the recovery signals, we a...

Accumulate Cadila Healthcare; target of Rs 1220: KRChoksey

6.29 pm | 12 Aug 2014 |  Source: Moneycontrol.com

KRChoksey is bullish on Cadila Healthcare and has recommended accumulate rating on the stock with a target of Rs 1220 in its July 31, 2014 research re...

Hold Cadila Healthcare; target of Rs 1300: Sharekhan

11.59 am | 05 Aug 2014 |  Source: Moneycontrol.com

Sharekhan has recommended a hold rating on Cadila Healthcare with a target price of Rs 1300 per share in its July 30, 2014 research report....

Buy Cadila Healthcare; target of Rs 1205: Motilal Oswal

6.05 pm | 01 Aug 2014 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target of Rs 1205 in its July 30, 2014 research repor...

1 2 3
Quick Links for Cadila Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.